Abstract
Proper centrosome numbers are imperative for faithful cell division, as aberrant centrosome numbers can lead to chromosomal instability, a hallmark of cancer development (Nigg 2002; Ganem et al., 2009). Hence, initiation of centriole duplication has to be tightly regulated. Recently, we and others demonstrated that Polo-like kinase 4 (Plk4) fulfills a pivotal role in regulating this process (Bettencourt-Dias et al., 2005; Habedanck et al., 2005). Plk4 protein levels and its activity directly correlate with centriole numbers: depletion of Plk4 leads to sequential loss of centrioles in successive cell divisions (Bettencourt-Dias et al., 2005; Habedanck et al., 2005) and its overexpression promotes bona fide overduplication of centrioles (Habedanck et al., 2005; Kleylein-Sohn et al., 2007), while both lead to progressive increase in abnormal spindle formation (reviewed in Nigg 2007). Even though Plk4 is a key regulator of centriole biogenesis and is crucial for maintaining constant centriole number, the mechanisms regulating its activity and expression are only beginning to emerge. Here, we show that human Plk4 is subject to beta-TrCP-dependent proteasomal degradation, indicating that this pathway is conserved from Drosophila to human (Cunha-Ferreira et al., 2009; Rogers et al., 2009). Unexpectedly, we found that stable overexpression of kinase-dead Plk4 leads to centriole overduplication. Our data indicate that this phenotype depends on the presence of endogenous wild-type Plk4 and that centriole overduplication results from disruption of Plk4 trans-autophosphorylation by kinase-dead Plk4, which then shields endogenous Plk4 from recognition by beta-TrCP. We conclude that active Plk4 promotes its own degradation by catalyzing beta-TrCP binding through trans-autophosphorylation within homodimers which has been independently confirmed by others (Holland et al., 2010). Additionally, we propose that Plk4 autophosphorylation is not sufficient for its degradation and that instead an additional kinase is required for this process.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.